Riva N - Search Results

1

Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

Dentali F, Riva N, Crowther M, Turpie AG, Lip GY, Ageno W. Dentali F, et al. Among authors: riva n. Circulation. 2012 Nov 13;126(20):2381-91. doi: 10.1161/CIRCULATIONAHA.112.115410. Epub 2012 Oct 15. Circulation. 2012. PMID: 23071159 Review.

2

Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events.

Dentali F, Riva N, Gianni M, Malato A, Bozzato S, Bernasconi M, Tuttolomondo A, Romano A, Pinto A, Siragusa S, Ageno W. Dentali F, et al. Among authors: riva n. Thromb Res. 2008;123(1):67-71. doi: 10.1016/j.thromres.2008.01.009. Epub 2008 Mar 6. Thromb Res. 2008. PMID: 18328541

3

Incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio.

Dentali F, Riva N, Malato A, Saccullo G, Siragusa S, Ageno W. Dentali F, et al. Among authors: riva n. J Thorac Cardiovasc Surg. 2009 Jan;137(1):91-3. doi: 10.1016/j.jtcvs.2008.06.030. Epub 2008 Aug 15. J Thorac Cardiovasc Surg. 2009. PMID: 19154909 Free article.

4

Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis.

Dentali F, Ageno W, Becattini C, Galli L, Gianni M, Riva N, Imberti D, Squizzato A, Venco A, Agnelli G. Dentali F, et al. Among authors: riva n. Thromb Res. 2010 Jun;125(6):518-22. doi: 10.1016/j.thromres.2010.03.016. Epub 2010 May 7. Thromb Res. 2010. PMID: 20451960

5

Unmet clinical needs in the management of patients with splanchnic vein thrombosis.

Riva N, Rancan E, Ageno W, Dentali F. Riva N, et al. Intern Emerg Med. 2010 Dec;5(6):459-61. doi: 10.1007/s11739-010-0473-7. Epub 2010 Nov 4. Intern Emerg Med. 2010. PMID: 21052865 No abstract available.

6

Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation.

Riva N, Smith DE, Lip GY, Lane DA. Riva N, et al. Age Ageing. 2011 Nov;40(6):653-5. doi: 10.1093/ageing/afr128. Epub 2011 Sep 27. Age Ageing. 2011. PMID: 21951858 No abstract available.

7

Nebivolol for the treatment of heart failure.

Riva N, Lip GY. Riva N, et al. Expert Opin Investig Drugs. 2011 Dec;20(12):1733-46. doi: 10.1517/13543784.2011.625011. Epub 2011 Oct 8. Expert Opin Investig Drugs. 2011. PMID: 21980961 Review.

8

Oral antithrombotic therapy and gastrointestinal bleeding: the good, the bad and the ugly.

Riva N, Apostolakis S, Lip GY. Riva N, et al. Int J Clin Pract. 2012 Jan;66(1):2-4. doi: 10.1111/j.1742-1241.2011.02828.x. Int J Clin Pract. 2012. PMID: 22171897 No abstract available.

9

A new era for anticoagulation in atrial fibrillation. Which anticoagulant should we choose for long‑term prevention of thromboembolic complications in patients with atrial fibrillation?

Riva N, Lip GY. Riva N, et al. Pol Arch Med Wewn. 2012;122(1-2):45-53. Pol Arch Med Wewn. 2012. PMID: 22353706 Free article. Review.

10

Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study.

Ageno W, Riva N, Noris P, Di Nisio M, La Regina M, Arioli D, Ria L, Monzani V, Cuppini S, Lupia E, Giorgi Pierfranceschi M, Dentali F; FONDAIR study group. Ageno W, et al. Among authors: riva n. J Thromb Haemost. 2012 Nov;10(11):2291-7. doi: 10.1111/j.1538-7836.2012.04908.x. J Thromb Haemost. 2012. PMID: 22925036 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

376 results

Search Page

Filters